SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-009109
Filing Date
2024-02-01
Accepted
2024-02-01 06:39:01
Documents
18
Period of Report
2024-01-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm244517d1_8k.htm   iXBRL 8-K 36431
2 EXHIBIT 99.1 tm244517d1_ex99-1.htm EX-99.1 633096
3 EXHIBIT 99.2 tm244517d1_ex99-2.htm EX-99.2 682133
8 GRAPHIC tm244517d1_ex99-1img001.jpg GRAPHIC 11682
  Complete submission text file 0001104659-24-009109.txt   1671910

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mrk-20240129.xsd EX-101.SCH 4141
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mrk-20240129_def.xml EX-101.DEF 27973
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrk-20240129_lab.xml EX-101.LAB 38099
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrk-20240129_pre.xml EX-101.PRE 26585
19 EXTRACTED XBRL INSTANCE DOCUMENT tm244517d1_8k_htm.xml XML 8224
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

IRS No.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06571 | Film No.: 24584980
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)